As of November 6, 2026, 2 holders' latest Schedule 13D or 13G filings report owning 5% or more of Shl Telemedicine Ltd. The largest reported stake is Value Base Ltd.'s, at 15.18%. 2 filings are on record since December 5, 2025 (Schedule 13D/A, December 5, 2025).
Sell to companies like Shl Telemedicine Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Shl Telemedicine Ltd has 2 Schedule 13D or 13G filings on record since 2025-12-05. 2 holders' latest filing reports 5% or more of american depositary shares, each representing one ordinary share, par value nis 0.01 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Value Base Ltd. | 15.18% | 5,624,944 | SCHEDULE 13D/A, 2025-12-05 | 2025-12-03 |
| Danbar Finance Ltd. | 9.9% | 3,165,620 | SCHEDULE 13D/A, 2025-12-15 | 2025-12-02 |
Holding shares or following this stake? See who's behind Shl Telemedicine Ltd and the warning signs.
Free to see. No signup.
Keep reading
More on Shl Telemedicine Ltd and the records around it.
Companies that share a holder
- Value Base Ltd. also filed stake reports on 4 other companies: Audiocodes Ltd (May 2026), RadCom Ltd (Mar 2026), Valens Semiconductor Ltd. (Nov 2025)
Watch Shl Telemedicine Ltd
Get an email when Shl Telemedicine Ltd files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Shl Telemedicine Ltd?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Shl Telemedicine Ltd: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Shl Telemedicine Ltd covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
2 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Value Base Ltd. | 0 | 5,624,944 | 0 | 5,624,944 | SCHEDULE 13D/A, 2025-12-05 |
| Value Base Hedge Fund Ltd., acting as the general partner to Harmony Base, Limited Partnership | 0 | 5,624,944 | 0 | 5,624,944 | SCHEDULE 13D/A, 2025-12-05 |
| Ido Nouberger | 0 | 5,624,944 | 0 | 5,624,944 | SCHEDULE 13D/A, 2025-12-05 |
| Victor Shamrich | 0 | 5,624,944 | 0 | 5,624,944 | SCHEDULE 13D/A, 2025-12-05 |
| Danbar Finance Ltd. | 3,165,620 | 0 | 3,165,620 | 0 | SCHEDULE 13D/A, 2025-12-15 |
| Miri Wulkan | 490,528 | 3,165,620 | 490,528 | 3,165,620 | SCHEDULE 13D/A, 2025-12-15 |
| Nir Rotenberg | 175,562 | 3,165,620 | 175,562 | 3,165,620 | SCHEDULE 13D/A, 2025-12-15 |
The latest filing identifies Shl Telemedicine Ltd by CUSIP 78423T200 and gives its principal executive office as 94 Yigal Alon Street, Tel Aviv (SCHEDULE 13D/A, 2025-12-15).
Source of funds (Item 3)
Item 3 of the Schedule 13D is amended to add the following: On December 3, 2025, the Issuer announced completion of a rights offering in which each of the Reporting Persons subscribed fully (the "Rights Offering"). In the Rights Offering, the Reporting Persons paid the Issuer approximately $0.76 per Ordinary Share, investing an aggregate of approximately $3.2 million, as follows: Mr. Nouberger has invested approximately $0.8 million in personal funds to acquire 1,128,168 Ordinary Shares he owns directly; Mr.Value Base Ltd., SCHEDULE 13D/A, 2025-12-05
This item is not being amended by this Schedule 13D/A.Danbar Finance Ltd., SCHEDULE 13D/A, 2025-12-15
Purpose of Transaction (Item 4)
Value Base Ltd.
Item 4 of the Schedule 13D is amended to add the following: The information set forth in Item 3 is incorporated herein by reference.Item 4 of the SCHEDULE 13D/A filed 2025-12-05
Danbar Finance Ltd.
This item is not being amended by this Schedule 13D/A.Item 4 of the SCHEDULE 13D/A filed 2025-12-15
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-12-05 | Value Base Ltd. | 15.18% | SCHEDULE 13D/A |
| 2025-12-15 | Danbar Finance Ltd. | 9.9% | SCHEDULE 13D/A |
Questions about who owns Shl Telemedicine Ltd
Who owns Shl Telemedicine Ltd?
On this page, 2 holders' latest ownership filings report 5% or more of Shl Telemedicine Ltd: Value Base Ltd. (15.18%, Schedule 13D/A, filed 2025-12-05) and Danbar Finance Ltd. (9.9%, Schedule 13D/A, filed 2025-12-15).
Who are the largest shareholders of Shl Telemedicine Ltd?
By the share each holder's latest filing reports, the largest holders of Shl Telemedicine Ltd on this page are Value Base Ltd. (15.18%) and Danbar Finance Ltd. (9.9%).
When did Value Base Ltd. buy into Shl Telemedicine Ltd?
The filings give report dates, not purchase dates. The earliest filing from Value Base Ltd. on this page is the Schedule 13D/A, filed 2025-12-05, reporting 15.18%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 2 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Shl Telemedicine Ltd. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.